569 related articles for article (PubMed ID: 31055032)
1. A cost-minimization analysis of treatment options for postmenopausal women with dysuria.
Bradley MS; Beigi RH; Shepherd JP
Am J Obstet Gynecol; 2019 Nov; 221(5):505.e1-505.e7. PubMed ID: 31055032
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of urinary tract infections across age groups.
Chu CM; Lowder JL
Am J Obstet Gynecol; 2018 Jul; 219(1):40-51. PubMed ID: 29305250
[TBL] [Abstract][Full Text] [Related]
3. All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms.
Rothberg MB; Wong JB
J Gen Intern Med; 2004 May; 19(5 Pt 1):433-43. PubMed ID: 15109341
[TBL] [Abstract][Full Text] [Related]
4. An update on the management of urinary tract infections in the era of antimicrobial resistance.
Bader MS; Loeb M; Brooks AA
Postgrad Med; 2017 Mar; 129(2):242-258. PubMed ID: 27712137
[TBL] [Abstract][Full Text] [Related]
5. Role of antibiotic resistance in urinary tract infection management: a cost-effectiveness analysis.
Wang R; LaSala C
Am J Obstet Gynecol; 2021 Nov; 225(5):550.e1-550.e10. PubMed ID: 34418350
[TBL] [Abstract][Full Text] [Related]
6. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis.
McKinnell JA; Stollenwerk NS; Jung CW; Miller LG
Mayo Clin Proc; 2011 Jun; 86(6):480-8. PubMed ID: 21576512
[TBL] [Abstract][Full Text] [Related]
7. Can a simple urinalysis predict the causative agent and the antibiotic sensitivities?
Waseem M; Chen J; Paudel G; Sharma N; Castillo M; Ain Y; Leber M
Pediatr Emerg Care; 2014 Apr; 30(4):244-7. PubMed ID: 24651215
[TBL] [Abstract][Full Text] [Related]
8. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
Bader MS; Loeb M; Leto D; Brooks AA
Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
[TBL] [Abstract][Full Text] [Related]
9. Urinary Tract Infections in Long-term Care: Evaluation of Uropathogens, Antibiotic Susceptibility, and Empiric Treatment.
Bao W; Koro M; Loh GW; Ortiz A
Sr Care Pharm; 2022 Jun; 37(6):232-243. PubMed ID: 35610764
[No Abstract] [Full Text] [Related]
10. Effect of 5-Day Nitrofurantoin vs Single-Dose Fosfomycin on Clinical Resolution of Uncomplicated Lower Urinary Tract Infection in Women: A Randomized Clinical Trial.
Huttner A; Kowalczyk A; Turjeman A; Babich T; Brossier C; Eliakim-Raz N; Kosiek K; Martinez de Tejada B; Roux X; Shiber S; Theuretzbacher U; von Dach E; Yahav D; Leibovici L; Godycki-Cwirko M; Mouton JW; Harbarth S
JAMA; 2018 May; 319(17):1781-1789. PubMed ID: 29710295
[TBL] [Abstract][Full Text] [Related]
11. Management of complicated urinary tract infections in the era of antimicrobial resistance.
Bader MS; Hawboldt J; Brooks A
Postgrad Med; 2010 Nov; 122(6):7-15. PubMed ID: 21084776
[TBL] [Abstract][Full Text] [Related]
12. Acute Uncomplicated UTIs in Adults: Rapid Evidence Review.
Kurotschka PK; Gágyor I; Ebell MH
Am Fam Physician; 2024 Feb; 109(2):167-174. PubMed ID: 38393801
[TBL] [Abstract][Full Text] [Related]
13. The Activity of Fosfomycin Against Extended-Spectrum Beta-Lactamase-Producing Isolates of Enterobacteriaceae Recovered from Urinary Tract Infections: A Single-Center Study Over a Period of 12 Years.
Aris P; Boroumand MA; Rahbar M; Douraghi M
Microb Drug Resist; 2018 Jun; 24(5):607-612. PubMed ID: 29064348
[TBL] [Abstract][Full Text] [Related]
14. Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.
Al-Zarouni M; Senok A; Al-Zarooni N; Al-Nassay F; Panigrahi D
Med Princ Pract; 2012; 21(6):543-7. PubMed ID: 22722224
[TBL] [Abstract][Full Text] [Related]
15. Resistance profiles of urinary tract infections in general practice--an observational study.
Schmiemann G; Gágyor I; Hummers-Pradier E; Bleidorn J
BMC Urol; 2012 Nov; 12():33. PubMed ID: 23171154
[TBL] [Abstract][Full Text] [Related]
16. Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Gökçe İ; Çiçek N; Güven S; Altuntaş Ü; Bıyıklı N; Yıldız N; Alpay H
Balkan Med J; 2017 Sep; 34(5):432-435. PubMed ID: 28443576
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies.
Barry HC; Ebell MH; Hickner J
J Fam Pract; 1997 Jan; 44(1):49-60. PubMed ID: 9010371
[TBL] [Abstract][Full Text] [Related]
18. National patterns in the treatment of urinary tract infections in women by ambulatory care physicians.
Huang ES; Stafford RS
Arch Intern Med; 2002 Jan; 162(1):41-7. PubMed ID: 11784218
[TBL] [Abstract][Full Text] [Related]
19. French results of the ARESC study: clinical aspects and epidemiology of antimicrobial resistance in female patients with cystitis. Implications for empiric therapy.
Neuzillet Y; Naber KG; Schito G; Gualco L; Botto H
Med Mal Infect; 2012 Feb; 42(2):66-75. PubMed ID: 22264668
[TBL] [Abstract][Full Text] [Related]
20. Oral treatment options for patients with urinary tract infections caused by extended spectrum βeta-lactamase (ESBL) producing Enterobacteriaceae.
Raja NS
J Infect Public Health; 2019; 12(6):843-846. PubMed ID: 31176606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
